Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objective: Sustained inflammation originating from macrophages is a driving force of fibrosis progression and resolution. Monoacylglycerol lipase (MAGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. It is a proinflammatory enzyme that metabolises 2-arachidonoylglycerol, an endocannabinoid receptor ligand, into arachidonic acid. Here, we investigated the impact of MAGL on inflammation and fibrosis during chronic liver injury. Design: C57BL/6J mice and mice with global invalidation of MAGL (MAGL-/-), or myeloid-specific deletion of either MAGL (MAGL Mye-/-), ATG5 (ATG Mye-/-) or CB2 (CB2 Mye-/-), were used. Fibrosis was induced by repeated carbon tetrachloride (CCl 4) injections or bile duct ligation (BDL). Studies were performed on peritoneal or bone marrow-derived macrophages and Kupffer cells. Results: MAGL-/- or MAGL Mye-/- mice exposed to CCl 4 or subjected to BDL were more resistant to inflammation and fibrosis than wild-type counterparts. Therapeutic intervention with MJN110, an MAGL inhibitor, reduced hepatic macrophage number and inflammatory gene expression and slowed down fibrosis progression. MAGL inhibitors also accelerated fibrosis regression and increased Ly-6C low macrophage number. Antifibrogenic effects exclusively relied on MAGL inhibition in macrophages, since MJN110 treatment of MAGL Mye-/- BDL mice did not further decrease liver fibrosis. Cultured macrophages exposed to MJN110 or from MAGL Mye-/- mice displayed reduced cytokine secretion. These effects were independent of the cannabinoid receptor 2, as they were preserved in CB2 Mye-/- mice. They relied on macrophage autophagy, since anti-inflammatory and antifibrogenic effects of MJN110 were lost in ATG5 Mye-/- BDL mice, and were associated with increased autophagic flux and autophagosome biosynthesis in macrophages when MAGL was pharmacologically or genetically inhibited. Conclusion: MAGL is an immunometabolic target in the liver. MAGL inhibitors may show promising antifibrogenic effects during chronic liver injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cirrhosis | Myeloid cell‐specific deletion of Atg5 | Exacerbated CCl4‐induced liver fibrosis linked to enhanced inflammatory infiltrate | Lodder et al (2015), Habib et al (2019) |”
From Autophagy in major human diseases (2021) · cites this paper as Habib et al, 2019
In the citing paper
“In particular, atg5 deletion (Lodder et al, 2015; Habib et al, 2019) and genetic inhibition of LAP components (Wan et al, 2020) in the myeloid compartment exacerbate hepatic inflammation in mice with chronic liver injury, thus enhancing liver fibrosis.”
From Autophagy in major human diseases (2021) · cites this paper as Habib et al, 2019
In the citing paper
“and (ii) autophagy as a limiting factor to a pro‐inflammatory phenotype in macrophages.”
From Autophagy in major human diseases (2021) · cites this paper as Habib et al, 2019
Citations
Cites
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 934
Self-citation
Research works printed but not linked: 1
- 10.1016/j.celrep.2015.06.075 · DOI · Paper page
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Autophagy in liver diseases: Time for translation?
Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.026 · Cited by 378
Self-citationAccumulation of polystyrene microplastics induces liver fibrosis by activating cGAS/STING pathway
Shen, R., Yang, K., Cheng, X., Guo, C., Xing, X., Sun, H., Liu, D., Liu, X., & Wang, D. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.118986 · Cited by 264
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
Mashek, D. G. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101115 · Cited by 232
“Genetic or chemical inhibition of MAGL results in resistance to fibrosis triggered from carbon tetrachloride injections or bile duct ligation [154].”
Background
Metadata
- Authors
- Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., Mansouri, A., Brouillet, A., Tardelli, M., Weiss, E., Le Faouder, P., Guillou, H., Cravatt, B. F., Moreau, R., Trauner, M., & Lotersztajn, S.
- Affiliations
- Inserm (FR)
- Medical University of Vienna (AT)
- Université Toulouse III - Paul Sabatier (FR)
- Scripps Research Institute (US)
- Corresponding author
- Lotersztajn, Sophie
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2018-10-09
- Volume
- 68
- Issue
- 3
- Pages
- 522-532
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2897753115
- Cited by
- 91
- References
- 42
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 8 · 2023: 14 · 2022: 7 · 2021: 16 · 2020: 15 · 2019: 8 · 2018: 2
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Austrian Science Funds
- Association Française pour l’Etude du Foie
- Fondation pour la Recherche Médicale
- Institut National de la Santé et de la Recherche Médicale
- Agence Nationale de la Recherche
- Programme PHC Cedre
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- monoacylglycerol lipase, MAGL inhibition, liver fibrosis, liver inflammation, macrophages, Kupffer cells, 2-arachidonoylglycerol, endocannabinoids, autophagy, ATG5, CB2 receptor, chronic liver injury, bile duct ligation, carbon tetrachloride, immunometabolism
- MeSH terms
- Animals, Anti-Inflammatory Agents, Autophagy, Carbamates, Carbon Tetrachloride, Cell Count, Cells, Cultured, Drug Evaluation, Preclinical, Hydrolases, Liver, Liver Cirrhosis, Experimental, Macrophages, Male, Mice, Inbred C57BL, Monoacylglycerol Lipases, Succinimides, Cytokines, Mice, Knockout, Disease Progression, Inflammation Mediators, Receptor, Cannabinoid, CB2, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. https://app.cochat.ai/papers/10.1136/gutjnl-2018-316137
- The paper
- Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., Mansouri, A., Brouillet, A., Tardelli, M., Weiss, E., Le Faouder, P., Guillou, H., Cravatt, B. F., Moreau, R., Trauner, M., & Lotersztajn, S. (2019). Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. Gut. https://doi.org/10.1136/gutjnl-2018-316137
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.